advertisement

Topcon

Zhang Q 27

Showing records 1 to 25 | Display all abstracts from Zhang Q

96330 Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
Li F
Journal of Ophthalmology 2021; 2021: 3897952
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Shiuey EJ
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
96199 Association of serum retinol concentration with normal-tension glaucoma
Pang R
Eye 2022; 36: 1820-1825
96330 Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
Huo Y
Journal of Ophthalmology 2021; 2021: 3897952
96199 Association of serum retinol concentration with normal-tension glaucoma
Feng S
Eye 2022; 36: 1820-1825
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Mehran NA; Ustaoglu M
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
96330 Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
Ma L
Journal of Ophthalmology 2021; 2021: 3897952
96199 Association of serum retinol concentration with normal-tension glaucoma
Cao K
Eye 2022; 36: 1820-1825
96330 Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
Zhang Q
Journal of Ophthalmology 2021; 2021: 3897952
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Zhang Q
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
96199 Association of serum retinol concentration with normal-tension glaucoma
Sun Y
Eye 2022; 36: 1820-1825
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Razeghinejad R
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
96330 Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
Zhang H
Journal of Ophthalmology 2021; 2021: 3897952
96199 Association of serum retinol concentration with normal-tension glaucoma
Guo Y
Eye 2022; 36: 1820-1825
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Shukla AG
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
96330 Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
Yan X
Journal of Ophthalmology 2021; 2021: 3897952
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Shukla AG
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
96199 Association of serum retinol concentration with normal-tension glaucoma
Ma D
Eye 2022; 36: 1820-1825
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Kolomeyer NN
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
96330 Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
Geng Y
Journal of Ophthalmology 2021; 2021: 3897952
96199 Association of serum retinol concentration with normal-tension glaucoma
Pang CP
Eye 2022; 36: 1820-1825
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Kolomeyer NN
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
96330 Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
Tang G
Journal of Ophthalmology 2021; 2021: 3897952
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Myers JS
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
96199 Association of serum retinol concentration with normal-tension glaucoma
Liu X
Eye 2022; 36: 1820-1825

Issue 22-3

Change Issue


advertisement

Oculus